JNJ vs THRM · P/E 17, rev $49.37B vs P/E 49, rev $809.9M
Johnson & Johnson (JNJ) versus Gentherm Inc (THRM) — a side-by-side from cached financials, not a winner call.
Johnson & Johnson (JNJ) is a drug manufacturers - general company listed on US. It is led by Joaquin Duato.
Gentherm Inc (THRM) is a auto parts company listed on NASDAQ.
Latest reported JNJ revenue for 2026-06-28 was $49.37B. Net income was $10.77B. JNJ currently screens at market cap $375.37B and trailing P/E 17.4.
Latest reported THRM revenue for 2026-06-30 was $809.9M. Net income was $8.6M. THRM currently screens at market cap $1.10B and trailing P/E 49.1.
JNJ currently screens at market cap $375.37B and trailing P/E 17.4. THRM currently screens at market cap $1.10B and trailing P/E 49.1.
Not investment advice. Open the JNJ and THRM stock pages for the full models.
Not investment advice.